Archives20242023202220212020201920182017201620152014201320122011 December 17, 2018Appointment of NOMAD Read More December 07, 2018Update on Corporate Activities Read More November 01, 2018Nominated Adviser Status Read More September 26, 2018Interim results announcement for the six months ended 30 June 2018 Read More September 19, 2018Standford Capital Partners and Si Capital are appointed as joint broker Read More September 07, 2018IMM September 2018 Corporate Update Read More June 29, 20182018 Annual General Meeting – All Resolutions Passed Read More June 14, 2018ImmuPharma announces positive pre-clinical data on its CIDP programme Read More June 06, 2018Annual Report and Accounts Posted to Shareholders Read More May 29, 2018Further Analysis from its Pivotal Phase III Trial of Lupuzor™ in Patients with Systemic Lupus Erythematosus (SLE) Shows Positive Results in the Europe Cohort<sup>1</sup> Read More April 24, 2018Holding in company Read More April 23, 2018Immupharma PLC confident on Lupuzor’s™ future Read More 12
May 29, 2018Further Analysis from its Pivotal Phase III Trial of Lupuzor™ in Patients with Systemic Lupus Erythematosus (SLE) Shows Positive Results in the Europe Cohort<sup>1</sup> Read More
